Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000990803 | SCV001141844 | likely pathogenic | Retinitis pigmentosa 3 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001051097 | SCV001215230 | likely pathogenic | not provided | 2023-11-28 | criteria provided, single submitter | clinical testing | This sequence change affects codon 34 of the RP2 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the RP2 protein. This variant also falls at the last nucleotide of exon 1, which is part of the consensus splice site for this exon. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with autosomal dominant inherited retinal dystrophy (PMID: 28714225; Invitae). ClinVar contains an entry for this variant (Variation ID: 427872). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Rui Chen Lab, |
RCV000515686 | SCV000579429 | likely pathogenic | Leber congenital amaurosis | 2017-05-09 | no assertion criteria provided | research |